Cholesterol plays a critical role in hantavirus infection

This graphic shows the rodent reservoir for hantaviruses, the aerosolized free virus, and the cellular entry pathway where the virus is taken up by endocytosis and enters within the endosomal compartment. Credit: Hannah J. Barbian

Viruses mutate fast, which means they can quickly become resistant to anti-viral drugs. But viruses also depend on proteins and nutrients provided by their hosts, and therefore one strategy to identify new anti-viral drugs is to identify and target such host-cell components. A paper published on February 6th in PLOS Pathogens reports that proteins involved in the regulation of cholesterol are essential for hantavirus entry into human host cells.

There are only about 30 known human cases of hantavirus infection in the US per year (with the 2012 in Yosemite National Park a recent example), but hanta is among the most deadly known human viruses: between 30 and 40% of people who are diagnosed die from hantavirus pulmonary fever. People who have hantavirus are not contagious, transmission only occurs when humans breath in small particles that carry excrements from infected rodents.

Together with colleagues, Paul Bates and Kenneth Briley, from the University of Pennsylvania, USA, set out to identify factors and pathways in human that were important for hantavirus infection. They focused on a member of the hantavirus group called Andes virus (ANDV). For their experiments they used mostly less dangerous viruses that were genetically engineered to share some characteristics with ANDV, and then used ANDV itself to confirm that the results were true for hantavirus as well.

In two independent genetic screens (systematic searches), they identified four proteins that were involved in hantavirus infection, and all of them were part of a complex that regulates production in mammalian cells. The scientists next tested whether an experimental drug that targets one of the four proteins could prevent viral entry. They found that treating cells that originated from human airways with this drug before exposing them to virus resembling hanta made the cells less susceptible to virus infection.

Since one of the effects of this experimental drug is that it lowers cholesterol levels in cells, the researchers asked whether statins, a well-known group of cholesterol-lowering drugs that are taken daily by millions of people around the world, could also protect against hantavirus infection. Indeed, pre-treatment of human cells with mevastatin (a member of the statin group that lowers cholesterol by mechanisms that do not involve the proteins they had identified in their screen) made them less susceptible to ANDV infection.

The researchers say "The sensitivity of ANDV to safe, effective cholesterol-lowering drugs may suggest new treatments for ANDV infection and pathogenesis." Moreover, as cellular cholesterol balance has been found to be important for a number of other viruses as well, they hope that "targeting this process might lead to the development of broadly effective anti-virals".

More information: Petersen J, Drake MJ, Bruce EA, Riblett AM, Didigu CA, et al. (2014) The Major Cellular Sterol Regulatory Pathway Is Required for Andes Virus Infection. PLoS Pathog 10(2): e1003911. DOI: 10.1371/journal.ppat.1003911

Related Stories

Record incidence of hantavirus disease

Jul 24, 2013

2824 new cases of hantavirus disease were reported in Germany in 2012, the highest number ever in a single year. In the current issue of Deutsches Ärzteblatt International, Detlev Krüger and coauthors present the main f ...

Trick that aids viral infection is identified

Jan 30, 2014

Scientists have identified a way some viruses protect themselves from the immune system's efforts to stop infections, a finding that may make new approaches to treating viral infections possible.

Pressurized virus blasts its infectious DNA into human cells

Jul 24, 2013

The virus that causes those painful lip blisters known as cold sores has an internal pressure eight times higher than a car tire, and uses it to literally blast its infectious DNA into human cells, scientists are reporting ...

Recommended for you

Where Ebola battles are won

36 minutes ago

(HealthDay)—Four hospitals that are home to advanced biocontainment facilities have become America's ground zero in the treatment of Ebola patients.

Depression tied to worse lumbar spine surgery outcomes

3 hours ago

(HealthDay)—Depressive symptoms are associated with poorer long-term outcome in patients undergoing surgery for lumbar spinal stenosis (LSS), according to research published in the Oct. 1 issue of The Sp ...

Ebola death toll edging to 4,900 mark: WHO

3 hours ago

The death toll in the world's worst-ever Ebola outbreak has edged closer to 4,900, while almost 10,000 people have now been infected, new figures from the World Health Organization showed Wednesday.

US to track everyone coming from Ebola nations

3 hours ago

U.S. authorities said Wednesday that everyone traveling into the U.S. from Ebola-stricken nations will be monitored for symptoms for 21 days. That includes returning American aid workers, federal health employees ...

User comments